Antigen Analysis Microchip Using Magnetic Drive and Optical Bead Counting

The patent replaces the passive capillary force mechanism with an active magnetic field-based fluid drive system. Magnetic particles suspended in the assay sample serve as mediators, allowing external magnetic fields to control fluid movement patterns. This substitution enables uniform and controllable fluid flow through the microchannels, improving antigen-antibody reaction efficiency and detection sensitivity while maintaining the microchip's passive structural design.

The patent introduces magnetic particles as intermediary elements between the external magnetic field and the assay sample. These particles suspend in the fluid and respond to magnetic field gradients, translating magnetic field application into controlled fluid movement. This intermediary mechanism enables precise control over fluid flow patterns without requiring complex active pumping structures within the microchip itself.

The patent employs colorimetric detection using chromogenic substrates that undergo visible color changes upon enzymatic conversion by labeled antibodies. This approach replaces fluorescent labeling with a simpler optical detection method based on absorbance or color intensity measurements. The colorimetric response provides sufficient detection sensitivity for quantitative antigen analysis while eliminating the need for complex fluorescent sensor calibration, thereby reducing device complexity and cost.

The patent utilizes disposable microchip cartridges that integrate the assay reagents, magnetic particles, and detection components in a single-use format. This approach allows for simplified detection methodologies (such as colorimetric rather than fluorescent) in each disposable unit, reducing the need for expensive and complex calibration systems in the main instrument. The disposable nature ensures consistent performance without requiring recalibration, thereby reducing overall device complexity.

The patent segments the detection approach by using magnetic particles to spatially concentrate and separate immune complexes from unbound reagents. This segmentation allows for discrete measurement of bound versus unbound components, enabling more accurate quantification that is less dependent on overall signal intensity averaging. The physical separation facilitated by magnetic particles provides distinct measurable populations that improve quantification precision without complicating the analysis methodology.

The patent uses magnetic particles as intermediaries to enable alternative quantification methods. By magnetically separating and concentrating immune complexes, these particles allow for measurement approaches such as bead counting or separated phase analysis that are less sensitive to variations in sensor calibration. The magnetic particles serve as a physical mediator that translates antigen-antibody binding events into easily quantifiable physical separations, improving accuracy while maintaining method simplicity.